Edura Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.05 M
as on 08-12-2024
- Revenue 42.11%
(FY 2020)
- Profit 36.58%
(FY 2020)
- Ebitda 118.21%
(FY 2020)
- Net Worth 47.36%
(FY 2020)
- Total Assets 30.19%
(FY 2020)
About Edura Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.05 M.
Rajan Vohra, Vikas, and Vikas Gambhir serve as directors at the Company.
- CIN/LLPIN
U52311DL2010PTC206871
- Company No.
206871
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Edura Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajan Vohra  | Director | 09-Aug-2010 | Current |
| Vikas | Director | 15-Nov-2010 | Current |
| Vikas Gambhir | Director | 13-Feb-2017 | Current |
Financial Performance of Edura Pharmaceuticals.
Edura Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.11% increase. The company also saw a substantial improvement in profitability, with a 36.58% increase in profit. The company's net worth Soared by an impressive increase of 47.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edura Pharmaceuticals?
In 2019, Edura Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Edura Infracon Private LimitedActive 2 years 5 monthsRajan Vohra, Vikas and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Feb 2023 | ₹2.00 M | Open |
Axis Bank Limited Creation Date: 27 Jan 2022 | ₹2.05 M | Open |
How Many Employees Work at Edura Pharmaceuticals?
Unlock and access historical data on people associated with Edura Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edura Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
